摘要 |
<p>Provided herein are Aminopurine Compounds having the following structure: (I) wherein R<SUP>1 </SUP>, R<SUP>2</SUP> and and R<SUP>3</SUP> are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.</p> |
申请人 |
SIGNAL PHARMACEUTICALS, LLC;ALBERS, RONALD;AYALA, LETICIA;CLAREEN, STEVEN, S.;DELGADO MEDEROS, MARIA, M.;HILGRAF, ROBERT;HEDGE, SAYEE;HUGHES, KEVIN;KOIS, ADAM;PLANTEVIN-KRENITSKY, VERONIQUE;MCCARRICK, MEG;NADOLNY, LISA;PALANKI, MOORTHY;SAHASRABUDHE, KIRAN;SAPIENZA, JOHN;SATOH, YOSHITAKA;SLOSS, MARIAN;SUDBECK, ELISE;WRIGHT, JONATHAN |
发明人 |
ALBERS, RONALD;AYALA, LETICIA;CLAREEN, STEVEN, S.;DELGADO MEDEROS, MARIA, M.;HILGRAF, ROBERT;HEDGE, SAYEE;HUGHES, KEVIN;KOIS, ADAM;PLANTEVIN-KRENITSKY, VERONIQUE;MCCARRICK, MEG;NADOLNY, LISA;PALANKI, MOORTHY;SAHASRABUDHE, KIRAN;SAPIENZA, JOHN;SATOH, YOSHITAKA;SLOSS, MARIAN;SUDBECK, ELISE;WRIGHT, JONATHAN |